Acutus Goes Public To Compete With Established Electrophysiology Players

The IPO is expected to raise $166m to support R&D of new arrhythmia mapping and ablation technologies and expand commercial operations.

Initial Public Offering IPO Stock Market Ticker
• Source: shutterstock.com

Acutus Medical, Inc.’s initial public offering (IPO) will give the company up to $166m to help take on its much larger competitors in the electrophysiology sector, such as Johnson & Johnson/Biosense Webster and Abbott .

“The offering was very well-received, and we're really pleased with the outcome,” Acutus CEO Vince Burgess told Medtech Insight following...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Financing

More from Business